Medical
The company produces stable isotopes for the nuclear medicine sector.

ASP Isotopes enriches stable isotopes for medical, semiconductor, and nuclear energy customers with Aerodynamic Separation Process and Quantum Enrichment technologies.
aspisotopes.comCrawled Oct 15, 2026
The company produces stable isotopes for the nuclear medicine sector.
The company aims to become part of the semiconductor supply chain.
ASP Isotopes originated in the South African Uranium Enrichment Program of the 1980s and uses two proprietary technologies for enrichment.
People People LEADERSHIP Paul E. MannChairman of the Board, Chief Executive Officer Paul Mann co-founded ASP Isotopes in September 2021 and serves as the
ASP Isotopes Inc. was incorporated in 2021 though its origins date back to South Africa’s uranium enrichment program in the 1980s. The company is comprised of
The page offers periodic updates on important company developments.
Isotopes are two or more atoms of the same chemical element with the same number of protons and electrons but slightly different numbers of neutrons.
ASP Isotopes Inc.’s website does not automatically collect personally identifiable information and tracks certain information about visits.
ASP Isotopes Inc. states that it does not disclose, give, sell, or transfer visitors’ personal information unless required by law enforcement or statute.
This site and all of its contents, including all text and images (collectively “Content”) are owned or licensed by ASP Isotopes Inc. All rights are reserved
ASP Isotopes Inc. hosts its inaugural Capital Markets Day in London and provides an operational update across its businesses. Management outlines the company's strategy across nuclear medicine, electronics, helium and LNG, and nuclear fuels.
The Texas A&M Engineering Experiment Station (TEES) signs a research agreement with Quantum Leap Energy (QLE) to advance and de-risk commercial production of high-purity uranium hexafluoride (UF6). The partnership’s stated objective combines progress toward commercial production with efforts to reduce risks in that production process.
ASP Isotopes restarts its Silicon-28 facility and locks in commercial shipments for Q3 2026. The company is also making progress across silicon, helium, and uranium.
ASP Isotopes says it has completed drilling the wells required for Phase 1 of the Renergen Helium Project approximately four months ahead of schedule. The advanced materials company develops technologies and processes for producing critical materials used in multiple industries.
ASP Isotopes Inc. closes its acquisition of Renergen, a South African natural gas and helium producer. Renergen operates the Virginia Gas Project.